Product Code: IRTNTR74160
Technavio has been monitoring the alpha glucosidase inhibitors market and it is poised to grow by $ 567.96 mn during 2022-2026, accelerating at a CAGR of 2.51% during the forecast period. Our report on the alpha glucosidase inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in awareness of diabetes and growing initiatives, growing awareness about benefits of alpha glucosidase inhibitors, and increasing prevalence of dumping syndrome globally.
The alpha glucosidase inhibitors market analysis includes the disease type segment and geographic landscape.
Technavio's alpha glucosidase inhibitors market is segmented as below:
By Disease Type
- Type 2 diabetes
- Dumping syndrome
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the growing geriatric population as one of the prime reasons driving the alpha glucosidase inhibitors market growth during the next few years. Also, availability of novel and improved alpha glucosidase inhibitors and increasing r and d on alpha glucosidase inhibitors will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on alpha glucosidase inhibitors market covers the following areas:
- Alpha glucosidase inhibitors market sizing
- Alpha glucosidase inhibitors market forecast
- Alpha glucosidase inhibitors market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading alpha glucosidase inhibitors market vendors that include Anderson Hay and Grain Co. Inc., AstraZeneca Plc, Bayer AG, BioVision Inc., Border Valley Trading, Bristol Myers Squibb Co., C. H. Boehringer Sohn AG and Co. KG, Eli Lilly and Co., GSK Plc, Glenmark Pharmaceuticals Ltd, Merck KGaA, Novartis AG, Novo Nordisk AS, Pfizer Inc., Sanofi, Straight Healthcare, Sun Pharmaceutical Industries Ltd., and Takeda Pharmaceutical Co. Ltd. Also, the alpha glucosidase inhibitors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary - Chart on Market Overview
- Exhibit 02: Executive Summary - Data Table on Market Overview
- Exhibit 03: Executive Summary - Chart on Global Market Characteristics
- Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
- Exhibit 05: Executive Summary - Chart on Market Segmentation by Disease Type
- Exhibit 06: Executive Summary - Chart on Incremental Growth
- Exhibit 07: Executive Summary - Data Table on Incremental Growth
- Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.3 Market size 2021
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Disease Type
- 5.1 Market segments
- Exhibit 24: Chart on Disease Type - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Disease Type - Market share 2021-2026 (%)
- 5.2 Comparison by Disease Type
- Exhibit 26: Chart on Comparison by Disease Type
- Exhibit 27: Data Table on Comparison by Disease Type
- 5.3 Type 2 diabetes - Market size and forecast 2021-2026
- Exhibit 28: Chart on Type 2 diabetes - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Type 2 diabetes - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Type 2 diabetes - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Type 2 diabetes - Year-over-year growth 2021-2026 (%)
- 5.4 Dumping syndrome - Market size and forecast 2021-2026
- Exhibit 32: Chart on Dumping syndrome - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Dumping syndrome - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Dumping syndrome - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Dumping syndrome - Year-over-year growth 2021-2026 (%)
- 5.5 Market opportunity by Disease Type
- Exhibit 36: Market opportunity by Disease Type ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
- Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 40: Chart on Geographic comparison
- Exhibit 41: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.5 Asia - Market size and forecast 2021-2026
- Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.8 Germany - Market size and forecast 2021-2026
- Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
- 7.9 UK - Market size and forecast 2021-2026
- Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
- 7.10 China - Market size and forecast 2021-2026
- Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
- 7.11 Japan - Market size and forecast 2021-2026
- Exhibit 74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on Japan - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
- 7.12 Market opportunity By Geographical Landscape
- Exhibit 78: Market opportunity By Geographical Landscape ($ million)
8 Drivers, Challenges, and Trends
- 8.1 Market drivers
- 8.2 Market challenges
- 8.3 Impact of drivers and challenges
- Exhibit 79: Impact of drivers and challenges in 2021 and 2026
- 8.4 Market trends
9 Vendor Landscape
- 9.1 Overview
- 9.2 Vendor landscape
- Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 81: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 82: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 83: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 84: Matrix on vendor position and classification
- 10.3 Anderson Hay and Grain Co. Inc.
- Exhibit 85: Anderson Hay and Grain Co. Inc. - Overview
- Exhibit 86: Anderson Hay and Grain Co. Inc. - Product / Service
- Exhibit 87: Anderson Hay and Grain Co. Inc. - Key offerings
- 10.4 Bayer AG
- Exhibit 88: Bayer AG - Overview
- Exhibit 89: Bayer AG - Business segments
- Exhibit 90: Bayer AG - Key offerings
- Exhibit 91: Bayer AG - Segment focus
- 10.5 Border Valley Trading
- Exhibit 92: Border Valley Trading - Overview
- Exhibit 93: Border Valley Trading - Product / Service
- Exhibit 94: Border Valley Trading - Key offerings
- 10.6 Eli Lilly and Co.
- Exhibit 95: Eli Lilly and Co. - Overview
- Exhibit 96: Eli Lilly and Co. - Product / Service
- Exhibit 97: Eli Lilly and Co. - Key offerings
- 10.7 Glenmark Pharmaceuticals Ltd
- Exhibit 98: Glenmark Pharmaceuticals Ltd - Overview
- Exhibit 99: Glenmark Pharmaceuticals Ltd - Product / Service
- Exhibit 100: Glenmark Pharmaceuticals Ltd - Key offerings
- 10.8 Merck KGaA
- Exhibit 101: Merck KGaA - Overview
- Exhibit 102: Merck KGaA - Business segments
- Exhibit 103: Merck KGaA - Key news
- Exhibit 104: Merck KGaA - Key offerings
- Exhibit 105: Merck KGaA - Segment focus
- 10.9 Pfizer Inc.
- Exhibit 106: Pfizer Inc. - Overview
- Exhibit 107: Pfizer Inc. - Product / Service
- Exhibit 108: Pfizer Inc. - Key news
- Exhibit 109: Pfizer Inc. - Key offerings
- 10.10 Sanofi
- Exhibit 110: Sanofi - Overview
- Exhibit 111: Sanofi - Business segments
- Exhibit 112: Sanofi - Key news
- Exhibit 113: Sanofi - Key offerings
- Exhibit 114: Sanofi - Segment focus
- 10.11 Sun Pharmaceutical Industries Ltd.
- Exhibit 115: Sun Pharmaceutical Industries Ltd. - Overview
- Exhibit 116: Sun Pharmaceutical Industries Ltd. - Product / Service
- Exhibit 117: Sun Pharmaceutical Industries Ltd. - Key offerings
- 10.12 Takeda Pharmaceutical Co. Ltd.
- Exhibit 118: Takeda Pharmaceutical Co. Ltd. - Overview
- Exhibit 119: Takeda Pharmaceutical Co. Ltd. - Product / Service
- Exhibit 120: Takeda Pharmaceutical Co. Ltd. - Key news
- Exhibit 121: Takeda Pharmaceutical Co. Ltd. - Key offerings
11 Appendix
- 11.1 Scope of the report
- 11.2 Inclusions and exclusions checklist
- Exhibit 122: Inclusions checklist
- Exhibit 123: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 124: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 125: Research methodology
- Exhibit 126: Validation techniques employed for market sizing
- Exhibit 127: Information sources
- 11.5 List of abbreviations
- Exhibit 128: List of abbreviations